Conclusion
To conclude, severe hypercholesterolemia mediated by Lp-X in post-HSCT patients with liver GVHD is a recognized yet overlooked phenomenon. Transplant physicians and endocrinologists should have increased awareness of this association and avoid unnecessary and ineffective usage of statins.